Brimonidine
Brimonidine is an approved active ingredient.
Chemical compound
What it is used for
- Glaucoma
- Open-angle glaucoma
- Rosacea
- Ocular hypertension
- Intraocular pressure
- Erythema
- Ocular changes
- Arterial hypertension
- Skin disease
Brimonidine tartrate ophthalmic solution, 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Mirvaso is indicated for the symptomatic treatment of facial erythema of rosacea in adult patients.
How it works
- Adrenergic receptor alpha-2 agonist
Common side effects
The following clinically significant adverse reactions are described elsewhere in the labeling: • Neonates and Infants (Pediatric Patients Younger than 2 Years Old) • Potentiation of Vascular Insufficiency • Severe Cardiovascular Disease • Contamination of Topical Ophthalmic Products After Use Most common adverse…
Who should not take it
Neonates and infants (pediatric patients younger than 2 years old). • Hypersensitivity to any component of this product. 4.1 Neonates and Infants (Pediatric Patients Younger than 2 Years Old) Brimonidine tartrate ophthalmic solution, 0.15% is contraindicated…
Pregnancy and breastfeeding
There are no adequate and well-controlled studies with brimonidine tartrate ophthalmic solution, 0.15% in pregnant women.
It is not known whether brimonidine tartrate is excreted in human milk.
Interactions
Brand names
United States
Alphagan P · Lumify · Lumify Preservative Free · Mirvaso · Qoliana
European Union
Mirvaso
Canada
Alphagan P · Brimonidine P · Jamp Brimonidine · Lumify · Med-Brimonidine · Onreltea · Riva-Brimonidine · Sandoz Brimonidine
Other trade names
Brymont
Approval status
- US Food and Drug Administration
- prescription and over-the-counter products · since 1996
- European Medicines Agency
- authorised · since 2014
- Health Canada
- prescription and over-the-counter products · marketed
- First approval anywhere
- 1996
Codes
- ATC
- D11AX21, S01EA05, S01GA07
- RxNorm CUI
- 134615
- ChEMBL
- CHEMBL844
- PubChem CID
- 2435
- UNII
- E6GNX3HHTE
- Wikidata
- Q577377
Frequently asked questions
What is Brimonidine used for?
Brimonidine is used for: Glaucoma, Open-angle glaucoma, Rosacea, Ocular hypertension, Intraocular pressure, Erythema, Ocular changes, and Arterial hypertension.
What are the brand names of Brimonidine?
Brand names of Brimonidine include Alphagan P, Lumify, Lumify Preservative Free, Mirvaso, Qoliana, Brimonidine P, Jamp Brimonidine, and Med-Brimonidine.
Medicines in the same class
- Caffeine
- Diclofenac
- Magnesium sulfate
- Ivermectin
- Finasteride
- Minoxidil
- Tacrolimus
- Calcium gluconate
- Oxymetazoline
- Eflornithine
- Pyrithione zinc
- Epinephrine
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)